By February 2025, the Sun‑Shi protocol received Fast‑Track FDA Breakthrough Device designation. Over 200 ALS clinics worldwide adopted the technology, and 15 % of newly diagnosed patients now start disease‑modifying therapy within three months of symptom onset—double the historical average.
Little’s family, armed with the scan’s quantitative data, opted for a clinical trial of a novel antisense oligonucleotide targeting his specific SOD1 mutation. The trial’s primary endpoint was a stabilization of NHI scores for at least six months. At the 6‑month mark, Little’s NHI plateaued at 42 / 100—a modest but meaningful halt to the rapid decline seen in his first year.
The kite that once flew over the sunlit dunes now hung in his room, a reminder that science can turn a fleeting ray into a steady beam. ALSScan.24.02.26.Molly.Little.Where.The.Sun.Shi...
"Just watched the most captivating movie - 'Where The Sun Shines Bright' (working title, might not be the actual title). The actress Molly Little was absolutely phenomenal in it. Her performance was so convincing and heartfelt that it felt like she was truly living through every scene.
The movie, much like its title suggests, explores themes of hope, resilience, and the pursuit of dreams under the sun. It's about finding light in dark times and the transformation that comes with it. By February 2025 , the Sun‑Shi protocol received
If you're looking for a film that leaves you feeling inspired and maybe even a bit changed, then 'Where The Sun...' is definitely worth checking out. I'd love to hear what you think of it if you've seen it too!
#MollyLittle #WhereTheSunShines #Inspiration #MovieNight" "Just watched the most captivating movie - 'Where
On February 26, 2024, a thin ribbon of frost clung to the windows of the Neuro‑Imaging Lab at the coastal research institute. Inside, Molly Chen, a 34‑year‑old neurologist‑engineer, was hunched over a laptop, eyes flicking between a cascade of data points and a faded photograph taped to the wall.
The picture showed a smiling five‑year‑old boy named Little—Molly’s nephew—holding a bright yellow sun‑shaped kite. The caption read, “Where the Sun shines, we play.”
Little had been diagnosed with amyotrophic lateral sclerosis (ALS) at the age of three, a rare pediatric form that progresses far faster than the adult disease. The diagnosis had come after months of unexplained weakness, a battery of EMGs, and a heartbreaking muscle biopsy. The family’s hope rested on one promise: detect the disease earlier, monitor it more precisely, and intervene before irreversible loss of motor neurons.
Molly’s own research, a collaborative project between neurologists, physicists, and data scientists, aimed to create a non‑invasive, ultra‑high‑resolution brain‑spinal cord scan—the “Sun‑Shi” (Sun‑Sharp Imaging) protocol—that could spot the tiniest signs of motor‑neuron degeneration before symptoms appeared.